Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2–59 Months of Age, Mongolia, 2015–2021

Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2–59 Months of Age, Mongolia, 2015–2021

Starting in June 2016, the 13-valent pneumococcal conjugate vaccine (PCV13) was introduced into the routine immunization program of Mongolia by using a 2+1 dosing schedule, phased by district. We used prospective hospital surveillance to evaluate the vaccine’s effect on pneumonia incidence rates am...

Full description

Bibliographic Details
Main Authors: Claire von Mollendorf, Munkhchuluun Ulziibayar, Cattram D. Nguyen, Purevsuren Batsaikhan, Bujinlkham Suuri, Dashtseren Luvsantseren, Dorj Narangerel, John de Campo, Margaret de Campo, Bilegtsaikhan Tsolmon, Sodbayar Demberelsuren, Eileen M. Dunne, Catherine Satzke, Tuya Mungun, E. Kim Mulholland
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2024-03-01
Series:Emerging Infectious Diseases
Subjects:
pneumonia
pneumococcal conjugate vaccine
PCV13
hospitalization
children
bacteria
Online Access:https://wwwnc.cdc.gov/eid/article/30/3/23-0864_article

Internet

https://wwwnc.cdc.gov/eid/article/30/3/23-0864_article

Similar Items